Tema Heart & Health ETF (NASDAQ:HRTS – Get Free Report) was the recipient of a large drop in short interest during the month of September. As of September 15th, there was short interest totaling 917 shares, a drop of 82.2% from the August 31st total of 5,158 shares. Currently, 0.1% of the shares of the company are sold short. Based on an average daily trading volume, of 2,266 shares, the days-to-cover ratio is currently 0.4 days.
Hedge Funds Weigh In On Tema Heart & Health ETF
Large investors have recently bought and sold shares of the stock. XML Financial LLC acquired a new stake in Tema Heart & Health ETF in the 2nd quarter worth $223,000. Anson Capital Inc. acquired a new position in shares of Tema Heart & Health ETF during the second quarter valued at about $297,000. Members Advisory Group LLC acquired a new position in shares of Tema Heart & Health ETF during the second quarter valued at about $398,000. Rothschild Capital Partners LLC bought a new stake in shares of Tema Heart & Health ETF in the second quarter valued at about $651,000. Finally, Royal Bank of Canada lifted its stake in shares of Tema Heart & Health ETF by 8.8% in the first quarter. Royal Bank of Canada now owns 21,083 shares of the company’s stock valued at $710,000 after buying an additional 1,703 shares during the period.
Tema Heart & Health ETF Stock Up 0.2%
Shares of HRTS stock traded up $0.06 during trading hours on Friday, reaching $36.30. 505 shares of the company’s stock were exchanged, compared to its average volume of 5,581. Tema Heart & Health ETF has a fifty-two week low of $29.54 and a fifty-two week high of $38.87. The stock has a market capitalization of $53.72 million, a P/E ratio of 22.06 and a beta of 0.63. The business has a fifty day moving average price of $37.07 and a 200-day moving average price of $35.30.
Tema Heart & Health ETF Company Profile
The Tema Obesity & Cardiometabolic ETF (HRTS) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that concentrates on companies focused on the treatment of cardiovascular diseases and/or metabolic diseases from companies all around the world. Using both top-down and bottom-up stock selection, the fund identifies innovative companies deemed attractive. HRTS was launched on Nov 20, 2023 and is issued by Tema.
See Also
- Five stocks we like better than Tema Heart & Health ETF
- 3 Defense Stocks Riding Nuclear, Missile, and Aerospace Demand
- SoFi Is Bypassing the Banking Bottleneck With Stablecoin Settlement
- These 3 Overlooked Stocks Have Big Money Behind Them
- Darden Restaurants Serves Up Fresh Catalysts for a Stock Price Rally
Receive News & Ratings for Tema Heart & Health ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tema Heart & Health ETF and related companies with MarketBeat.com's FREE daily email newsletter.
